alendronate has been researched along with cyclosporine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Mochizuki, T; Nemoto, R; Okabe, K; Satou, S | 1 |
| Bowman, AR; Epstein, S; Jee, WS; Ma, Y; Sass, DA; Yuan, Z | 1 |
| Jeffery, JR; Karpinski, ME; Leslie, WD; Nickerson, PW; Rush, DN | 1 |
| Drexel, H; Hoefle, G; Holzmueller, H | 1 |
| Dejardin, A; Devogelaer, JP; Goffin, E | 1 |
| Marcantonio, E; Marcantonio, RA; Nassar, CA; Nassar, PO; Rossa, C; Spolidorio, DM; Spolidorio, LC | 1 |
| Abrahamsen, B; Andersen, LS; Ellingsen, T; Hansen, I; Hansen, MS; Hetland, ML; Hyldstrup, L; Hørslev-Petersen, K; Jensen, TW; Junker, P; Jurik, AG; Langdahl, B; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Petersen, K; Svendsen, AJ; Tarp, U; Vestergaard, A; Zerahn, B; Østergaard, M | 1 |
1 review(s) available for alendronate and cyclosporine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for alendronate and cyclosporine
| Article | Year |
|---|---|
Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate.
Topics: Adult; Alendronate; Azathioprine; Bone Density; Bone Resorption; Calcitriol; Calcium Channel Agonists; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone | 2003 |
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Topics: Adult; Aged; Alendronate; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome; Young Adult | 2014 |
7 other study(ies) available for alendronate and cyclosporine
| Article | Year |
|---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
Topics: Alendronate; Animals; Bone Neoplasms; Bone Resorption; Calcitonin; Cyclosporine; Diphosphonates; Female; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Omeprazole; Osteoclasts; Osteolysis; Urinary Bladder Neoplasms | 1992 |
Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Topics: Administration, Oral; Alendronate; Analysis of Variance; Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Calcitriol; Calcium; Cyclosporine; Disease Models, Animal; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Subcutaneous; Male; Osteocalcin; Osteoclasts; Parathyroid Hormone; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia | 1997 |
Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Topics: Alendronate; Bone Resorption; Calcitriol; Calcium; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Vitamin D | 2004 |
Alendronate versus calcitriol for prevention of bone loss after cardiac transplantation.
Topics: Alendronate; Bone Density; Bone Resorption; Calcitriol; Creatinine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Prednisone; Renal Insufficiency; Tacrolimus | 2004 |
Alendronate therapy in cyclosporine-induced alveolar bone loss in rats.
Topics: Acid Phosphatase; Alendronate; Alkaline Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Biomarkers; Bone Density; Bone Density Conservation Agents; Calcium; Cell Count; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Isoenzymes; Male; Osteoblasts; Osteocalcin; Osteoclasts; Random Allocation; Rats; Rats, Wistar; Tartrate-Resistant Acid Phosphatase | 2007 |